Tumor necrosis factor-α inhibitor-related autoimmune disorders
L De Stefano, FB Pallavicini, E Mauric, V Piccin… - Autoimmunity …, 2023 - Elsevier
Biotechnological monoclonal antibodies and receptor antagonists capable of targeting
specific inflammatory actors, such as cytokines, cytokines receptors, co-stimulatory …
specific inflammatory actors, such as cytokines, cytokines receptors, co-stimulatory …
Tumor necrosis factor-α inhibitor-related autoimmune disorders
L De Stefano, FB Pallavicini, E Mauric… - AUTOIMMUNITY …, 2023 - iris.unipv.it
Biotechnological monoclonal antibodies and receptor antagonists capable of targeting
specific inflammatory actors, such as cytokines, cytokines receptors, co-stimulatory …
specific inflammatory actors, such as cytokines, cytokines receptors, co-stimulatory …
Tumor necrosis factor-α inhibitor-related autoimmune disorders
L De Stefano, FB Pallavicini, E Mauric, V Piccin… - Autoimmunity …, 2023 - Elsevier
Biotechnological monoclonal antibodies and receptor antagonists capable of targeting
specific inflammatory actors, such as cytokines, cytokines receptors, co-stimulatory …
specific inflammatory actors, such as cytokines, cytokines receptors, co-stimulatory …
Tumor necrosis factor-α inhibitor-related autoimmune disorders
L De Stefano, FB Pallavicini, E Mauric… - Autoimmunity …, 2023 - pubmed.ncbi.nlm.nih.gov
Biotechnological monoclonal antibodies and receptor antagonists capable of targeting
specific inflammatory actors, such as cytokines, cytokines receptors, co-stimulatory …
specific inflammatory actors, such as cytokines, cytokines receptors, co-stimulatory …